U.S. Infrastructure Stock News

NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Is Blackbaud (BLKB) Fully Valued After Its AI And Expedited Giving Rollout?

Blackbaud (BLKB) has caught fresh attention after extending its Expedited Giving services and introducing a Microsoft 365 Copilot agent for Raiser’s Edge NXT. These moves focus on faster donations and easier access to fundraising data. See our latest analysis for Blackbaud. Blackbaud’s recent AI and payments launches have coincided with a sharp 30 day share price return of 41.25% and a 90 day share price return of 55.84%, although the 1 year total shareholder return has declined 28.50%. This...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart Holdings (UPST) Is Up 5.2% After Detailing Plans For Upstart Bank And Secured Lending Shift

Earlier this week, Upstart CEO Paul Gu outlined that the company is entering a “second leg” of its development, aiming to turn its artificial-intelligence lending platform into sustained profitable growth while expanding into secured products and preparing to launch Upstart Bank. A distinct takeaway for investors is management’s plan to have newer home and auto lending lines contribution-profitable by year-end, signalling a tighter focus on capital efficiency and product diversification...
NYSE:NSC
NYSE:NSCTransportation

Norfolk Southern (NSC) Stock Looks Overvalued After A 75% Three Year Run

Norfolk Southern stock has delivered a strong 74.9% return over the past three years, yet the latest intrinsic value estimate from a Discounted Cash Flow (DCF) model suggests the shares trade at a premium to that cash flow based view. At the same time, traditional market multiples look roughly in line with peers, which leaves the recent performance and the current price sending mixed signals about value. Norfolk Southern's 74.9% three year return points to investors already paying up for the...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

SBA Communications (SBAC) Stock Looks Like A Bargain Below Fair Value

SBA Communications stock has had a difficult run over the past five years, yet the current share price of US$182.43 looks cheap when set against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and traditional valuation multiples that both point to undervaluation. The share price has declined 43.3% over the past five years, which suggests investors have grown cautious even as valuation indicators now lean supportive. Future cash flow growth from SBA Communications' tower...
NYSE:TREX
NYSE:TREXBuilding

How Trex’s Q2 2026 Margin Squeeze and Buybacks Will Impact Trex Company (TREX) Investors

In the second quarter of 2026, Trex Company reported higher sales but lower net income year-on-year, completed a large share repurchase, authorized a new buyback program, and reaffirmed full‑year sales guidance. This combination of earnings pressure, ongoing capital returns, and unchanged revenue outlook offers a clearer view of how management is balancing growth ambitions with shareholder payouts. Next, we'll examine how Trex's reaffirmed sales guidance, despite margin pressure, influences...
NYSE:HSY
NYSE:HSYFood

Hershey (HSY) Stock Looks Below Fair Value On Cash Flow

Hershey stock has delivered a 21.9% total return over the past five years, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples indicate the shares are priced on the high side. Hershey's 21.9% five year return suggests the stock has rewarded patient investors over a medium term horizon. Future cash flow and margin expectations can support the DCF view of upside. However, any pressure on consumer...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

Nutex Health (NUTX) Could Be 28% Undervalued Following Its 28th Hospital Opening

Nutex Health (NUTX) has drawn fresh investor attention after opening its 28th hospital nationwide and third facility in Arkansas, expanding emergency care capacity and advanced imaging access in West Little Rock. See our latest analysis for Nutex Health. For investors, Nutex Health’s latest hospital opening adds to a period of strong momentum, with a 60.35% 90 day share price return and a very large 3 year total shareholder return of 323.60%, alongside a 105.52% total shareholder return over...
NYSE:WLY
NYSE:WLYMedia

Wiley (WLY) Stock May Be 44% Undervalued Despite New Spectral Analysis APIs

John Wiley & Sons stock has delivered a 76.2% return year to date, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach indicate that the shares may still trade below that intrinsic value by a wide margin. The 76.2% year to date return suggests investors have rapidly repriced John Wiley & Sons. The key issue now is whether the fundamentals justify that move. Recent launches in its spectral analysis APIs and updated mass spectral library...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics (IOVA) Stock Could Be Rich Following Its 217% Run

Iovance Biotherapeutics stock has delivered a steep 217.1% return year to date, yet current checks point to shares trading on the expensive side when compared with fundamental metrics. For investors, that mix of strong momentum and a market multiple that screens as overvalued raises questions about how much upside is already reflected in the price. The year to date gain of 217.1% suggests expectations for Iovance Biotherapeutics have reset sharply higher and now carry a lot more...
NYSE:KR
NYSE:KRConsumer Retailing

Kroger (KR) Stock Looks Like A Bargain On Value But Full On Earnings

Kroger stock has delivered a 36.9% total return over the past five years, yet with the shares down 19.9% over the last year and the valuation checks pointing to value in several areas, investors are weighing whether the current price still offers a reasonable entry point or is closer to fully reflecting the fundamentals. A 36.9% return over five years suggests Kroger has rewarded patient shareholders. This raises the question of how much of that progress is already reflected in today’s share...